Cavalier Jason

Chief Financial Officer at LYRA

Sold, on record
$9k
Dollars the filings state
Form 4 sales
2
Latest Jan 6, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LYRALyra Therapeutics, Inc.Chief Financial Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale LYRARoutine
    Jul 10, 2025 2025

    Sold 684 shares at $8.91 ($6k)

    Cavalier Jason, Chief Financial Officer

    10b5-1 planSold 0.1% of holdings ($4.6M position)519,316 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LYRARoutine
    Jan 6, 2026 +180 days

    Sold 769 shares at $3.36 ($3k)

    Cavalier Jason, Chief Financial Officer

    10b5-1 planSold 0.1% of holdings ($1.7M position)518,547 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Cavalier Jason
Source
Jan 6, 2026Jan 8, 2026LYRAChief Financial OfficerForm 4 sale769$3k0.1%RoutineSEC
Jul 10, 2025Jul 14, 2025LYRAChief Financial OfficerForm 4 sale684$6k0.1%RoutineSEC